The Charles T. Campbell Eye Microbiology Lab
University of Pittsburgh Schools of the Health Sciences
HomeAbout UsLab Diagnostic TestingAntibiotic SusceptibilityAntimicrobial TherapyCurrent ResearchContact Us


Ocular Microbiology and Immunology Group (OMIG)
Back to OMIG Main Page

2008 Abstracts and Meeting Agenda

Agenda
Ocular Microbiology and Immunology Group
42nd Annual Meeting
Westin Peachtree Plaza
November 7, 2008

MODERATORS:      Michael Zegans, M.D., Ph.D.
                                    David Ritterband, M.D.

6:45 am Registration
7:30 am

Decreased Childhood Mortality With Mass Azithromydin Distributions For Trachoma

  • Keenan J, Porco T, House J, Hong K, Zhou Z,  Stoller N, Whitcher J, Gaynor B, Lietman , T
    F.I.  Proctor Foundation, University Of California, San Francisco
7:38 am

Subconjunctival/perilesional Recombinant Interferon Alpha 2b for Ocular Surface Squamous Neoplasia: a 10 year review

  • Scott D. Barnes M.D., Carol L. Karp, M.D., Sachin Chabra M.D., Anat Galor M.D., Eduardo C. Alfonso, M.D.,  Bascom Palmer Eye Institute, University of Miami

7:46 am

Genotypic Identification of Fusarium sp from Ocular Sources and Correlation to Clinical Outcomes.

  • R A Oechsler1,2, M R Feilmeier1, D R Ledee1, D Miller1, M R Diaz3, M E Fini1, J W Fell3, E C Alfonso1.
    1
    Bascom Palmer Eye Institute - Miller School of Medicine - University of Miami, Miami, FL; 2Ophthalmology Department, Federal University of Sao Paulo, Sao Paulo, Brazil; 3Rosenstiel School of Marine and Atmospheric Science - University of Miami, Miami, FL.
7:54 am

Nocardia Scleritis and Keratitis: A Case Series

  • Mark D. Ewald, MD, Elisabeth J Cohen MD (sponsor), Peter R Laibson MD, Christopher J Rapuano MD, Kristin M Hammersmith MD
    Cornea Department, Wills Eye Hosptial, Jefferson Univeristy
8:02 am

Culture-positive Endophthalmitis after Implantation of a Staar Intraocular Collamer Lens

  • Michael J. Davis, M.D.1,3, Randy J. Epstein, M.D.1,2, Jack A. Cohen, M.D.1,3, Richard F. Dennis, M.D.1,2.
    1Rush University Medical Center, Department of Ophthalmology
    2Chicago Cornea Consultants, Chicago, IL. 3Illinois Retina Associates, Chicago, IL
8:10 am

A New Staphylococcus aureus Rabbit Endophthalmitis Model and the Effectiveness of Fourth Generation Fluoroquinolones

  • Balzli CL, McCormick CC, Caballero A, Newman E, O’Callaghan RJ
    University of Mississippi Medical Center Microbiology Department
8:18 am

Three Different Preventive Methods for Endophthalmitis; Which is the Best?

  • S Kobayakawa1, A Tsuji2, T Tochikubo1.
    1
    Department of Ophthalmology, Toho University, Tokyo, Japan.
    2 Department of Infection Control and Prevention, School of Nursing, Faculty of Medicine, Toho University, Tokyo, Japan.
8:26 am

cAMP-phosphodiesterase activity mediates bacterial biofilm formation

  • Robert M. Q. Shanks,Eric J. Kalivoda, Nicholas A. Stella, James E. Fender
    Campbell Laboratory, Department of Ophthalmology, University of Pittsburgh
8:34 am

A Genetic Screen Identified Novel Regulators of Serratia marcescens virulence factor production.

  • Eric J. Kalivoda, Nicholas A. Stella, James E. Fender
    Campbell Laboratory, Department of Ophthalmology, University of Pittsburgh
8:42 am

Role of Microbial Cell Wall Products in Culture Negative Contact Lens Associated Keratitis.

  • Darlene Miller, DHSc, E.C. Alfonso, MD
    Bascom Palmer Eye Institute, Miami, FL
8:50 am

Clinical isolates of P. aeruginosa harbor bacteriophages and CRISPR genes

  • Rory T. Allar1, Kyle C. Cady1, John H. Hammond1, George A. O’Toole1, Michael E. Zegans1,2
    1Department of Microbiology and Immunology, 2Department of Surgery (Ophthalmology) Dartmouth Medical School, Hanover, NH
8:58 am

A multi-center, pediatric comparison of polymixin B sulfate/trimethoprim ophthalmic solution and moxifloxacin in the treatment of bacterial conjunctivitis.

  • 1Mark Dorfman, MD;2David B Granet,MD; 3 David Stroman,PhD; 3Paul Cockrum, PharmD
    1Joe DiMaggio Children’s Hospital, Hollywood FL;
    2 Ratner Children’s Eye Center, University of California – San Diego, La Jolla, CA;
    3 Alcon Research Ltd, Fort Worth, TX
9:06 am

Comparison of In Vitro Susceptibilities of Gatifloxacin and Moxifloxacin Against Gram Positive Cocci Isolated from Ocular Infections.

  • Ashok Kumar Reddy1, PhD, Prashant Garg2, MD, Md. Rajeeb Alam3, DO, Usha Gopinathan11 PhD. Savitri Sharma1, MD. Sannapaneni Krishnaiah, MPS.
    1.Jhaveri Microbiology Centre, Hyderabad Eye Research Foundation, L.V.Prasad Eye Institute, Hyderabad, India.
    2.Cornea and Anterior Segment services, L.V.Prasad Eye Institute, Hyderabad, India.
    3.Cornea and Anterior Segment Services, M.A.I. Eye Institute and Hospital, Farmgate, Dhaka, Bangladesh.
    4.Internatoional Center for Advancement of Rural Eye Care, L.V.Prasad Eye Institute, Hyderabad, India.
9:14 am

Characterization of keratitis-associated Staphylococcus aureus infections from the Boston area

  • Irmgard Behlau1,2,3, Elizabeth M. Leonard1, Susan R. Heimer2,3, Jacqueline N. Martin1,2, Claes H. Dohlman1,2,3, Michael S. Gilmore1,2,3
    1Massachusetts Eye and Ear Infirmary, 2The Schepens Eye Research Institute,
    3Dept of Ophthalmology, Harvard Medical School, Boston, MA
9:22 am

In Vitro Susceptibility Testing of Staphylococcus aureus to a Cell-Associated Antibiotic

  • R.P. Kowalski, E.G. Romanowski, F.S.Mah, Y.J. Gordon, R.M.Q. Shanks.
    The Charles T. Campbell Laboratory, University of Pittsburgh, Pittsburgh, PA
9:30 am

Clinical Experience with Acanthamoeba Keratitis at the Cole Eye Institute, 1999-2008 

  • Qian Y, Meisler DM, Langston RHS, Jeng BH.
    Cole Eye Institute, Cleveland Clinic, Cleveland, OH

 

9:38 am

Is the Epidemic of Acanthamoeba Keratitis Over?

  • David Ritterband MD, Wilma Perez BS, John Seedor MD, Richard Koplin MD
    Departments of Ophthalmology and Laboratory Medicine The New York Eye and Ear Infirmary
9:46 am

Zymographic profiles of Acanthamoeba strains isolated from human corneal tissue

  • Denise de Freitas1, Fábio Ramos de Souza Carvalho1, Linda Christian Carrijo Carvalho2, Ana Marisa Chudzinsky-Tavassi2, Annette Silva Foronda1
    1. Federal University of Sao Paulo, Department of Ophthalmology; 2. Butantan Institute, Laboratory of Biochemistry and Biophysics
9:54 am

Endosymbionts as co-pathogens in Acanthamoeba keratitis

  • Lovieno1,2, D. Miller1, D. Ledee1, N. Mandal1, E. Alfonso1
    1Bascom Palmer Eye Institute, University of Miami – Miller Scool of Medicine, Miami, FL; 2Ophthalmology Department, University Campus Bio-medico, Rome, Italy
10:02 am

A prospective, randomized, double-masked, placebo-controlled trail of topical Polyhexamethylene biguanide (0.02%) in patients with Microsporidial keratoconjunctivitis.

  • Savitri Sharma, Srikant K Sahu, Sujata Kar, Shyam S Nayak
    L V Prassad Eye Institute, Bhubaneswar – 751024, Orissa, India
10:10 am

Cellular Changes of the Cornea in Herpes Simplex Keratitis: An in vivo Confocal Microscopy Study

  • Pedram Hamrah, MD; Mohammad H. Dastjerdi, MD; Reza Dana, MD, MSc, MPH; Deborah Pavan-Langston, MD
    Cornea & Refractive Surgery Service, Massachusetts Eye & Ear Infirmary
10:18 am

Cyclopentenylcytosine (CPE-C) Inhibits Adenovirus Replication in the Ad5/NZW Rabbit Ocular Model.

  • EG Romanowski, KA Yates, YJ Gordon
    The Charles T. Campbell Ophthalmic Microbiology Laboratory, UPMC Eye Center, Ophthalmology and Visual Sciences Research Center, Eye and Ear Institute, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA.
10:26 am

Effects of Topical Nanoviricides in Rabbit Model of EKC

  • V. Boniuk, H. Ailani  J. Jonisch. I.J. Udell  
    The Feinstein Institute for Medical Research, North Shore Long Island Jewish Department of Ophthalmology, New Hyde Park, NY



10:34 am

 

 

Topical Interferon Alpha 2b Eye Drops for Treatment of Ocular Surface Squamous Neoplasia: A Dose Comparison Study

  • Anat Galor MD, Carol L. Karp MD, Sachin Chhabra MD, Scott Barnes MD, Eduardo C. Alfonso MD
    Bascom Palmer Eye Institute, University of Miami
10:42

Thygeson Lecture

  • Jerold Gordon
    The 2008 Thygeson Lecture,
    "The Life and Times of Adenovirus 1899-2008".
11:00 am



Closing Comments and Awards

Adjourn

 

12:00pm

 

 

Lunch

 

                      

 

View OMIG Meeting Commercial Relationship Policy


 

OMIG Contact information:
John Sutphin, MD (jsutphin@kumc.edu)
University ofr Kansas Medical Center
3901 Rainbow Blvd, MS 3009
Kansas City, Kansas 66106
Phone (913) 588-0888

View Previous OMIG Meetings Abstracts

2007 Abstracts 2007 Meeting, Nov 19, 2007, New Orleans, LA
2006 Abstracts
2006 Meeting, Nov 10, 2006, Las Vegas, NV
2005 Abstracts 2005 Meeting, Oct 15, 2005, Chicago, IL
2004 Abstracts 2004 Meeting, Oct. 23, 2004, New Orleans, LA
2003 Abstracts 2003 Meeting, Nov. 15, 2003, Anaheim, CA
2002 Abstracts 2002 Meeting, Oct.19, 2002, Orlando, FL
2001 Abstracts 2001 Meeting, Nov.10, 2001, New Orleans, LA

 

 

Top of Page


Website Terms of Use | E-mail Terms of Use | Medical Advice Disclaimer | UPMC
Affiliated with the University of Pittsburgh Schools of the Health Sciences | Contact UPMC

 

 


OMIG logo
Image of Ocular Microbiology and Immunology Group (OMIG) logo.